Tag Archives: mergers and acquisitions

Zoll Medical Corporation Breach of Fiduciary Duty Investigation Concerning Acquisition by Asahi Kasei Corporation

Investigation into Breach of Fiduciary Duty Claims concerning the Acquisition of Zoll Medical Corporation by Asahi Kasei Corporation announced by Leading National Securities Law Firm Gilman Law LLP.

Investigation into Zoll Medical Acquisition by Asahi Kasei

Investigation into Zoll Medical Acquisition by Asahi Kasei

The National Securities Law Firm Gilman Law LLP has launched a breach of fiduciary duty investigation into possible breach of fiduciary duty claims concerning current shareholders of Zoll Medical Corporation (“Zoll”) (NASDAQ: ZOLL) and other violations of state law by the board of directors of Zoll relating to the proposed acquisition of Zoll by Asahi Kasei Corporation (“Asahi”). Gilman Law’s breach of fiduciary duty investigation seeks to determine whether the board breached its fiduciary duties by failing to maximize shareholder value in negotiating the agreement to sell the company to Asahi.

On March 12, 2012, Zoll and Asahi announced that they had entered into a definitive agreement providing for Asahi to acquire Zoll for approximately $2.1 billion. Under the terms of the Zoll acquisition merger agreement, Zoll shareholders will receive $93.00 for each share of Zoll common stock held. However, according to news media, at least one analyst has set a high price target of $100.00 per share. The transaction is expected to close in the second calendar quarter of 2012.

If you currently own shares of Zoll and would like to learn more about the breach of fiduciary duty investigation by the National Securities Law Firm Gilman Law LLP, you may contact our office for a free consultation by calling (239) 221-8301 or by filling out our free consultation form online.

About The Leading National Securities Law Firm Gilman Law LLP

The leading national securities law attorneys at Gilman Law have over 35 years of experience litigating securities and other class action cases. Our firm has been involved in all major aspects of securities litigation, including cases involving stock manipulation, securities fraud, investment fraud, and shareholder rights violations, as well as securities class action suits on behalf of both individual and institutional investors.

Posted in Closed Investigations & Lawsuits | Also tagged , , , , , | Leave a comment

Illumina Class Action Lawsuit Alleging Conflict of Interest in Proposed Acquisition by Roche

Illumina Class Action Lawsuit Announced by Gilman Law LLP on Behalf of Shareholders Alleging Conflict of Interest in Recent Proposed Acquisition by Roche

Illumina Class Action Lawsuit was filed by shareholders in Illumina, Inc.(NASDAQ:ILMN) alleging conflicts of interest in the recent proposed acquisition by Roche. The plaintiffs allege that the defendants breached their fiduciary duties by, among other things, by refusing to engage in negotiations and/or substantive dialogue with Roche which resulted in the defendants failing to get the best price for Illumina shareholders.

Those investors who purchased or otherwise acquired Illumina, Inc. shares and currently hold those shares should complete the free consultation. Investors may contact Gilman Law LLP by phone at (239) 221-8301, by email at kgilman@gilmanpastor.com, or by completing the free consultation form below.

Illumina Class Action Lawsuit Details

During December 2011, Roche communicated to top executives at Illumina, that Roche had an interest in acquiring Illumina. Plaintiffs claim that shortly thereafter Roche formally offered to acquire all of the shares of Illumina’s common stock. Instead of considering this offer or negotiating a higher bid, Defendants, at the advice of Goldman Sachs, flatly rejected the offer. Goldman Sachs benefited financial from its recommendation that Illumina reject the Roche offer.

On January 24, 2012, Roche publicly announced that it wanted to acquire all outstanding shares of Illumina, Inc. for $44.50 per share. Following the announcement Illumina shares surged on January 25, 2012 above the current offer and closed as high as $55.15.

Again, instead of negotiating a higher price Illumina announced on January 26, 2012 that its Board of Directors adopted a “Rights Agreement,” a/k/a poison pill, which allows directors to deflect offers for a company. Plaintiffs claim that defendants failed to act in the best interest of shareholders and failed to maximize the value shareholders would receive by depriving the Illumina, Inc. public stockholders of the opportunity to fully realize the benefits of their investment.

About Gilman Law LLP

The securities law attorneys of Gilman Law have more than 35 years of experience in securities law and have been involved in all major aspects of securities litigation. Gilman Law handles cases involving stock manipulation, securities fraud, investments fraud, shareholder rights violations, and securities arbitration.

Posted in Closed Investigations & Lawsuits | Also tagged , , , , | Leave a comment

Taleo Shareholder Lawsuit Alleging Breaches of Fiduciary Duties in Oracle Acquisition

Taleo Class Action Lawsuit Filed on Behalf of Investors in Taleo Corporation Alleging Breaches of Fiduciary Duty by the Taleo Board in Connection with Acquisition of Taleo by Oracle Corporation

Taleo Class Action Lawsuit was filed by Investors in Taleo Corporation (NASDAQ:TLEO) alleging breaches of fiduciary and violations of other state law against the Taleo Board in connection with the sale of the company to Oracle Corporation. Specifically, the complaint concerns whether the Taleo Board of Directors breached their fiduciary duties to Taleo stockholders by failing to adequately shop the Company before entering into this transaction and whether Oracle Corporation is underpaying for Taleo shares, thus unlawfully harming Taleo stockholders. Furthermore, at least one analyst set a price target 13% higher than the price offered per Taleo share.

Those investors who purchased or otherwise acquired Taleo Corporation shares and currently hold those shares should complete the free consultation. Investors may contact Gilman Law LLP by phone at (239) 221-8301, by email at kgilman@gilmanpastor.com, or by completing the free consultation form below.

About Gilman Law LLP

The securities law attorneys of Gilman Law have more than 35 years of experience in securities law and have been involved in all major aspects of securities litigation. Gilman Law handles cases involving stock manipulation, securities fraud, investments fraud, shareholder rights violations, and securities arbitration.

Posted in Closed Investigations & Lawsuits | Also tagged , , , | Leave a comment

Awards & Recognition

The Securities and Investment Fraud Attorneys at Gilman Law LLP have been recognized by numerous leading legal publications:

Investment Losses Law Firm